Real, D.A.; Bolaños, K.; Priotti, J.; Yutronic, N.; Kogan, M.J.; Sierpe, R.; Donoso-González, O.
Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics 2021, 13, 2131.
https://doi.org/10.3390/pharmaceutics13122131
AMA Style
Real DA, Bolaños K, Priotti J, Yutronic N, Kogan MJ, Sierpe R, Donoso-González O.
Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics. 2021; 13(12):2131.
https://doi.org/10.3390/pharmaceutics13122131
Chicago/Turabian Style
Real, Daniel Andrés, Karen Bolaños, Josefina Priotti, Nicolás Yutronic, Marcelo J. Kogan, Rodrigo Sierpe, and Orlando Donoso-González.
2021. "Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability" Pharmaceutics 13, no. 12: 2131.
https://doi.org/10.3390/pharmaceutics13122131
APA Style
Real, D. A., Bolaños, K., Priotti, J., Yutronic, N., Kogan, M. J., Sierpe, R., & Donoso-González, O.
(2021). Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability. Pharmaceutics, 13(12), 2131.
https://doi.org/10.3390/pharmaceutics13122131
